Moderate to Severe SARS-CoV-2 Infection Primes Vaccine-Induced Immunity More Effectively than Asymptomatic or Mild Infection

The authors assessed humoral and cellular immune responses against SARS-CoV-2 following recovery from infection, vaccine dose 1 and vaccine dose 2 in 35 persons recovered from COVID-19.